The committee of lawyers for the local governments suing the drug industry in federal courts called Tuesday’s verdict [11/23/21] “a milestone victory” and “overdue reckoning.” Not only were the drugs approved by the Food and Drug Administration (F.D.A.)… but the D.E.A. also set the annual limit on how many opioids could be produced in the…
“It’s time for psychedelic medicine to climb down from the ivory tower and into the community,” said Dr Belser. A recent survey… of adults in Oregon – the first state in the United States to legalize the therapeutic use of psilocybin mushrooms – found that on average, people would be willing to pay $100 for a psilocybin therapy…
The legalization campaign’s focus on vets as leading advocates is not without controversy. Carlos Plazola, co-founder of the advocacy group Decriminalize Nature, said he was disappointed by the movement’s overemphasis on the struggles of service members. He said a broader cross section of people of color should have their experiences heard. “We understand the value…
Their research was not cited in the patent application. Yet, if this patent application was granted… it could block others… The application, published on May 20 2020, was originally filed on November 15, 2019. (Patent applications are kept secret for 18 months)… the application has claims on organisms genetically modified to produce psilocybin by giving them…
Given promising clinical-trial results, many stakeholders are attempting to patent psychedelic compounds and methods of producing and administering them… the sudden interest in patenting psychedelics has prompted criticism from stakeholders, including patient advocates, scientists, journalists, lawyers and Indigenous communities… Weak psychedelic patents could potentially be invalidated in court, but that does not make them harmless,…
As psilocybin was isolated from the Psilocybe mexicana mushroom in 1957 and is a known compound, it lacks novelty… for being patentable, an invention must be “new” and “inventive”. Since most common psychedelics are known for many years, it is not possible to patent these existing substances (i.e. lack of novelty). The interest in psychedelics…
“The rule is if something already belongs to the public, you can’t take it away from them,” Gretchen Temeles, special counsel at the Philadelphia law firm… said in an interview. But Compass has also highlighted the threat from nonprofits like the Usona Institute, which does its own research on psychedelics. The IPO filing warned that…
As increasing numbers of U.S. states have legalized both medical and adult-use cannabis, another set of Schedule 1 controlled substances – psychedelics – has begun to emerge from the shadows. As was the case for cannabis, biomedical research into psychedelics ground nearly to a halt following the Schedule 1 designation. More than 50 years later and…
…nearly every day, another psychedelics company announces its work in securing patents for the intellectual property represented by the product they developed… a quick search of the USPTO site shows that there are currently hundreds of patents related to LSD and Psilocybin products and formulations. Psilocybin (U.S. Patent No. 3,183,172, “Obtaining Psilocybin and Psilocin from…
The story of CB, a 49-year-old woman, and her roommate, who witnessed the event. CB had contracted Lyme disease in her early 20s, and by the LSD event, she experienced significant pain in her feet and ankles, routinely taking morphine for a decade… CB snorted… pure LSD – 550 times the normal recreational dosage of…
